Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
With Teva Bid Off the Table, Mylan's Stock In 'Show-Me' Mode - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Teva Offers to Buy Mylan for $40 Billion - WSJ
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva Pharmaceuticals CEO: Stock on Track for 2020 Turnaround - RealMoney
Teva Part of Consortium Looking to Participate in Purdue Pharma's Bankruptcy, Report Says | Ctech
Teva Offers to Buy Mylan for $40 Billion - WSJ
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva Offers to Buy Mylan for $40 Billion - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva Offers to Buy Mylan for $40 Billion - WSJ
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva to Buy Generics Distributor Anda From Allergan for $500 Million - WSJ
Teva reaches proposed $4.35 billion settlement of U.S. opioid lawsuits By Reuters
Teva Pharmaceuticals - Wikipedia
Israel stocks at record; banks, Teva in focus - MarketWatch
Teva stock drops on guidance, manufacturing problems - MarketWatch
Pfizer, Takeda Reach $2.15 Billion Settlement With Teva, Sun Pharma - WSJ
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
